The Association Between Mutations in the Lysosomal Protein Glucocerebrosidase and Parkinsonism

被引:54
作者
DePaolo, John [1 ]
Goker-Alpan, Ozlem [1 ]
Samaddar, Ted [1 ]
Lopez, Grisel [2 ]
Sidransky, Ellen [1 ]
机构
[1] NHGRI, Sect Mol Neurogenet, Med Genet Branch, NIH, Bethesda, MD 20892 USA
[2] NINDS, Off Clin Director, Med Neurol Branch, NIH, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
parkinsonism; synucleinopathies; Gaucher disease; glucocerebrosidase; risk factor; MUTANT ALPHA-SYNUCLEIN; LEWY BODY DISORDERS; GAUCHER-DISEASE; GENE-MUTATIONS; EARLY-ONSET; RISK-FACTOR; ASHKENAZI-JEWS; MANIFESTATIONS; GBA; POPULATION;
D O I
10.1002/mds.22538
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
A body of work has emerged over the past decade demonstrating it relationship between mutations in glucocerebrosidase gene (GBA), the gene implicated in Gaucher disease (GD), and the development of parkinsonism. Several different lines of research Support this relationship. First, patients Willi GD who are homozygous for Mutations in GBA have a higher than expected propensity to develop Parkinson's disease (PD). Furthermore, carriers of GBA mutations, particularly family members of patients with GD. have displayed all increased rate of parkinsonism. Subsequently, investigators from centers around the world screened cohorts of patients with parkinsonism for GBA mutations and found that overall, subjects with PD, as well as other Lewy body disorders. have at least a fivefold increase in the number of carriers of GBA Mutations as compared to age-matched controls. In addition. neuropathologic Studies of Subjects with parkinsonism carrying GBA Mutations demonstrate Lewy bodies. depletion of neurons of the substantia nigra, and involvement of hippocampal layers CA2-4. Although the basis for this association has yet to be elucidated, evidence continues to support the role of GBA as a PD risk factor across different centers, synucleinopathies, and ethnicities. Further studies of the association between GD and parkinsonism will stimulate new insights into the pathophysiology of the two disorders and will prove crucial for both genetic counseling of patients and family members and the design of relevant therapeutic strategies for specific patients with parkinsonism. (C) 2009 Movement Disorder Society
引用
收藏
页码:1571 / 1578
页数:8
相关论文
共 51 条
[1]   Mutations in the glucocerebrosidase gene and Parkinson disease: Phenotype-genotype correlation [J].
Aharon-Peretz, J ;
Badarny, S ;
Rosenbaum, H ;
Gershoni-Baruch, R .
NEUROLOGY, 2005, 65 (09) :1460-1461
[2]   Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews [J].
Aharon-Peretz, J ;
Rosenbaum, H ;
Gershoni-Baruch, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (19) :1972-1977
[3]  
Beutler E., 2001, METABOLIC MOL BASES, V3, P3635
[4]   Clinical features of parkinsonian patients with the α-synuclein (G209A) mutation [J].
Bostantjopoulou, S ;
Katsarou, Z ;
Papadimitriou, A ;
Veletza, V ;
Hatzigeorgiou, G ;
Lees, A .
MOVEMENT DISORDERS, 2001, 16 (06) :1007-1013
[5]  
BRAS J, NEUROBIOL A IN PRESS
[6]   Emerging pathways in genetic Parkinson's disease: Potential role of ceramide metabolism in Lewy body disease [J].
Bras, Jose ;
Singleton, Andrew ;
Cookson, Mark R. ;
Hardy, John .
FEBS JOURNAL, 2008, 275 (23) :5767-5773
[7]   The Gaucher registry -: Demographics and disease characteristics of 1698 patients with Gaucher disease [J].
Charrow, J ;
Andersson, HC ;
Kaplan, P ;
Kolodny, EH ;
Mistry, P ;
Pastores, G ;
Rosenbloom, BE ;
Scott, CR ;
Wappner, RS ;
Weinreb, NJ ;
Zimran, A .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (18) :2835-2843
[8]   Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease [J].
Clark, L. N. ;
Ross, B. M. ;
Wang, Y. ;
Mejia-Santana, H. ;
Harris, J. ;
Louis, E. D. ;
Cote, L. J. ;
Andrews, H. ;
Fahn, S. ;
Waters, C. ;
Ford, B. ;
Frucht, S. ;
Ottman, R. ;
Marder, K. .
NEUROLOGY, 2007, 69 (12) :1270-1277
[9]   Pilot association study of the β-glucocerebrosidase N370S allele and Parkinson's disease in subjects of Jewish ethnicity [J].
Clark, LN ;
Nicolai, A ;
Afridi, S ;
Harris, J ;
Mejia-Santana, H ;
Strug, L ;
Cote, LJ ;
Louis, ED ;
Andrews, H ;
Waters, C ;
Ford, B ;
Frucht, S ;
Fahn, S ;
Mayeux, R ;
Ottman, R ;
Marder, K .
MOVEMENT DISORDERS, 2005, 20 (01) :100-103
[10]   Lipid droplet binding and oligomerization properties of the Parkinson's disease protein α-synuclein [J].
Cole, NB ;
Murphy, DD ;
Grider, T ;
Rueter, S ;
Brasaemle, D ;
Nussbaum, RL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (08) :6344-6352